Dr. Cheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Lakeville Road
New Hyde Park, NY 11042Phone+1 516-734-8776Fax+1 516-734-8862
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2006 - 2009
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
- NY State Medical License 2006 - 2025
- PA State Medical License 2009 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsA deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population.Coral Olazagasti, Chung-Shien Lee, Angel Liu, Dimitre G. Stefanov, Kit Cheng
Journal of Oncology Pharmacy Practice. 2021-10-19 - 55 citationsNovel microtubule-targeting agents – the epothilonesKit Cheng, Thomas Bradley, Daniel R Budman
Biologics. 2008-12-05 - 74 citationsAdjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M. Tolaney, Nabihah Tayob, Chau T. Dang, Denise A. Yardley, Steven J. Isakoff
Journal of Clinical Oncology. 2021-06-02
Press Mentions
- Combo Rx May Boost Ovarian Cancer Outcomes, but Too Few Get It: StudyAugust 3rd, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: